NCT01298531 - A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

April 30, 2013

Conditions

Axial Spondyloarthritis

Interventions

DRUG

etanercept

etanercept 50 mg subcutaneous (SC) injections once weekly for 16 weeks.

DRUG

etanercept

etanercept 50 mg subcutaneous (SC) injections once weekly for 8 weeks following the prior 8 weeks of placebo.

DRUG

placebo

placebo subcutaneous (SC) injections once weekly for 8 weeks.

Trial Locations (19)

31059

Hopital Purpan, Toulouse

33076

Hopital Pellegrin, Bordeaux

34000

CHU Lapeyronie, Immuno-Rhumatologie, Montpellier

42055

CHU de Saint Etienne, Hopital Nord, Saint-Etienne

45032

Hopital Porte Madeleine, Orléans

46000

Centre Hospitalier, Service de Rhumatologie, Cahors

62608

Institut Calot - Fondation Hopale, Berck

63003

CHU Hopital Gabriel Montpied, Clermont-Ferrand

72037

CH Le Mans, Le Mans

75012

H�al Saint-Antoine, Paris

75014

Hopital Cochin, Paris

Hopital Saint Joseph - Service de Rhumatologie, Paris

75018

Hopital Bichat, Paris

76031

CHU Bois Guillaume - Service de Rhumatologie, Rouen

87042

Chu Dupuytren, Rhumatologie et Therapeutique, Limoges

91100

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

94275

Hopital Bicetre, Le Kremlin-Bicêtre

06202

Hopital de l'Archet, Nice

75651 Cedex 13

Service de Rhumatologie, Paris